All In MedTech

Device Trial Radar · NCT07789782

Comparison of a New Non-invasive Device With the Invasive Gold-standard Investigation to Assess Function of the Large Bowel in Children

Validation of Body Surface Colonic Mapping, a Non-invasive Tool for Assessing Colonic Motility in Children

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Sep 2, 2026

Primary completion

Dec 2031

Study completion Dec 2031

Sponsor

Lead sponsor
Murdoch Childrens Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Royal Children's Hospital; Flinders University
First posted
Aug 27, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 6 months, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if the new non-invasive device (Body Surface Colonic Mapping) works to accurately assess colonic movement and function in children.The main questions it aims to answer are: * Are Body Surface Colonic Mapping (BSCM) recordings comparable with gold-standard colonic manometry recordings (HRCM - High Resolution Colonic Manometry) in the paediatric population? * What are the effects of bowel preparation on colonic function assessed using BSCM? Children with clinical recommendation of colonic and/or anorectal manometry (clinical tests used to assess colonic function) for investigation of persistent bowel dysfunction symptoms will be invited to participate. We will perform and compare simultaneous recordings of manometry and BSCM in children, in order to demonstrate same colonic function measurements recorded by the two devices in this population. Eligible participants who consent to inclusion in the study will undergo colonoscopy and placement of a large bowel catheter, according to usual Royal Children's Hospital (RCH) practice. These involve administration of oral laxatives for bowel preparation and maintaining a clear fluids diet 24 hours prior to the investigation. Ahead of the simultaneous devices recordings, patients will also be invited to attend the hospital 2-4 weeks prior to have non-invasive BSCM recording only. The aim of this part of the study is to have a BSCM recording in the same patient once with the "physiological state" colon (early hospital visit without any bowel preparation administration) and once with the "non-physiological state" colon (time of colonoscopy, colonic manometry and BSCM with bowel preparation).

Conditions

  • Bowel Dysfunction
  • Dysmotility
  • Hirschsprung Disease
  • Anorectal Malformations
  • Constipation
  • Functional Constipation (FC)

Interventions

  • Body Surface Colonic MappingDevice

    BSCM includes a sticky grid pad device connected to a reader that detects bowel motility. The sticky gid pad is the single-use disposable part of BSCM, so after use in each participant, the pads are disposed of. The grid pads are made of 64 electrodes and can be cut along pre-designed marks to allow for appropriate fitting on the child's abdomen. The sticky grid will be appropriately sized and applied to the patients' abdomen in the operating theatre recovery room after colonoscopy and correct positioning in relation to the manometry catheter will be ensured with an abdominal X-Ray (AXR). The device will be on the patients' abdomen until for the whole duration of the investigation (about 6 hours).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Outcome measure 1: Motility Index (MI) as measured by Body Surface Colonic Mapping (BSCM) (to be compared with the Motility Index of the alternative method [colonic manometry])Time frame: On the day of the main investigation, from the beginning of colonic manometry and BSCM assessments until the end of the tests, with an estimated testing time of 6 hours.
  2. Outcome measure 2: Motility Index (MI) as measured by colonic manometry (to be compared with the Motility Index of the alternative method [Body Surface Colonic Mapping])Time frame: On the day of the main investigation, from the beginning of colonic manometry and BSCM assessments until the end of the tests, with an estimated testing time of 6 hours.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Royal Children's Hospital / Murdoch Children's Research Institute

    Melbourne, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.